BANP and breast cancer: Further, quantitative analysis of SMAR1 staining in all breast cancer samples has revealed upto 2.5, 5.8 and 11 fold downregulation in mean fluorescence intensity (MFI) per 50 μm2 of the tissue area in IDC G-I, II and III as compared to the fibro-adenoma benign (Figure 1F).